Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord. Its cause is unknown and it is uniformly fatal, typically within five years. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8, 9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O2.- to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders, we investigated SOD1 as a candidate gene in FALS. We identified 11 different SOD1 missense mutations in 13 different FALS families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-standing associations of some forms of ALS with mutations in genes coding for superoxide dismutase 1”
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
DNA damage and oxygen radical toxicity
Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160
Carlioz, A., & Touati, D. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04256.x · Cited by 784
Centre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J., Cann, H., Cohen, D., Lathrop, M., Lalouel, J.-M., & White, R. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells.
Crapo, J. D., Oury, T., Rabouille, C., Slot, J. W., & Chang, L. Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10405 · Cited by 503
Richardson, J., Thomas, K. A., Rubin, B. H., & Richardson, D. C. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.4.1349 · Cited by 403
Familial adult motor neuron disease: amyotrophic lateralsclerosis
(1986) · Neurology · doi:10.1212/wnl.36.4.511 · Cited by 401
Self-citation
Research works printed but not linked: 7
- Kurland, L. T. Proc. Staff Meet Mayo Clin. 32, 449–462 (1957).
- Swerts, L. & Van Den Bergh, R. J. J. genet. Hum. 24, 247–255 (1976).
- Fridovich, I. Adv. Enzym. 58, 61–97 (1986).
- Ott, J. Am. hum. Genet. 28, 528–529 (1976).
- Ott, J. Analysis of Human Genetics 203–216 (Johns Hopkins Univ. Press, Baltimore, 1991).
- Hallewell, R. A. et al. in Superoxide Dismutase in Chemistry, Biology and Medicine (ed. Rotilio, G.) 249–256 (Elsevier, 1986).
- Muller, H. in Sixth internat. Congr. Genetics (ed. Jones, D.) 213–255 (Brooklyn Botanic Gardens, Menasha, 1932).
Cited by
Items 801–900 of 1,128
Boll, M.-C., Alcaraz-Zubeldia, M., Montes, S., & Rios, C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9610-3 · Cited by 173
“Mutations in the cytosolic copper enzyme SOD1 result in the motor neuron degeneration of some forms of familial amyotrophic lateral sclerosis [ 18 ] and current evidence suggests a direct pathogenic role of copper in this process [19].”
BackgroundMitochondrial dysfunction and intracellular calcium dysregulation in ALS
Kawamata, H., & Manfredi, G. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.05.003 · Cited by 173
“Mutations in Cu,Zn,superoxide dismutase (SOD1) are the most common and constitute about 20% of familial ALS (fALS) cases (Rosen et al., 1993).”
BackgroundHuman stem cells and drug screening: opportunities and challenges
Ebert, A. D., & Svendsen, C. N. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3000 · Cited by 172
Kawamata, H., & Manfredi, G. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3212 · Cited by 172
Freeman, L. R., & Keller, J. N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.009 · Cited by 172
Iwata‐Ichikawa, E., Kondo, Y., Miyazaki, I., Asanuma, M., & Ogawa, N. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722334.x · Cited by 173
The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)
Redler, R. L., & Dokholyan, N. V. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00002-3 · Cited by 172
“Studies of SOD1 mutant transgenic mice reveal proteasomal impairment in the disease-vulnerable spinal cord and brainstem only after the onset of symptoms307,308; so UPS dysfunction is unlikely to be an initiator of pathology in SOD1-related FALS.”
InfluentialWidespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis
Grosskreutz, J., Kaufmann, J., Frädrich, J., Dengler, R., Heinze, H.-J., & Peschel, T. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-17 · Cited by 172
“Familial cases constitute 5 – 10% of cases which are caused by mutations of the human superoxide dismutase in 20% of familial ALS [6,7].”
BackgroundUBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis
Williams, K. L., Warraich, S. T., Yang, S., Solski, J. A., Fernando, R., Rouleau, G. A., Nicholson, G. A., & Blair, I. P. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.008 · Cited by 170
Self-citationNogo Provides a Molecular Marker for Diagnosis of Amyotrophic Lateral Sclerosis
Dupuis, L., Gonzalez de Aguilar, J.-L., di Scala, F., Rene, F., de Tapia, M., Pradat, P.-F., Lacomblez, L., Seihlan, D., Prinjha, R., Walsh, F. S., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0522 · Cited by 172
Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis
Ding, H., Schwarz, D. S., Keene, A., Affar, E. B., Fenton, L., Xia, X., Shi, Y., Zamore, P. D., & Xu, Z. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00054.x · Cited by 170
Elevated “Hydroxyl Radical” Generation In Vivo in an Animal Model of Amyotrophic Lateral Sclerosis
Bogdanov, M. B., Ramos, L. E., Xu, Z., & Beal, M. F. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71031321.x · Cited by 171
Resveratrol: A Focus on Several Neurodegenerative Diseases
Tellone, E., Galtieri, A., Russo, A., Giardina, B., & Ficarra, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/392169 · Cited by 171
Novel Therapies Targeting Inner Mitochondrial Membrane—From Discovery to Clinical Development
Szeto, H. H., & Schiller, P. W. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0476-8 · Cited by 170
Winter, F. D., Vo, T., Stam, F. J., Wisman, L. A. B., Bär, P. R., Niclou, S. P., van Muiswinkel, F. L., & Verhaagen, J. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.03.002 · Cited by 171
Dissociation of Human Copper-Zinc Superoxide Dismutase Dimers Using Chaotrope and Reductant
Doucette, P. A., Whitson, L. J., Cao, X., Schirf, V., Demeler, B., Valentine, J. S., Hansen, J. C., & Hart, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409744200 · Cited by 171
Vitamin E and Neurodegenerative Disorders Associated with Oxidative Stress
Allan Butterfield, D., Castegna, A., Drake, J., Scapagnini, G., & Calabrese, V. (2002) · Nutritional Neuroscience · doi:10.1080/10284150290028954 · Cited by 171
“The mutation in CuZn-SOD is a gain-of-function alteration, resulting in more production of H2O2 (Gurney et al., 1994).”
BackgroundHentati, A., Ouahchi, K., Pericak-Vance, M. A., Nijhawan, D., Ahmad, A., Yang, Y., Rimmler, J., Hung, W.-Y., Schlotter, B., Ahmed, A., et al. (1998) · neurogenetics · doi:10.1007/s100480050052 · Cited by 171
Self-citationThe role of free radicals in disease*
Florence, T. M. (1995) · Australian and New Zealand Journal of Ophthalmology · doi:10.1111/j.1442-9071.1995.tb01638.x · Cited by 170
Zinc and Alzheimer's disease: is there a direct link?
Cuajungco, M. P., & Lees, G. J. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00002-7 · Cited by 170
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis
Corrado, L., Del Bo, R., Castellotti, B., Ratti, A., Cereda, C., Penco, S., Sorarù, G., Carlomagno, Y., Ghezzi, S., Pensato, V., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.071027 · Cited by 170
“gene have been found in ∼20% of all FALS pedigrees,”
BackgroundZetterström, P., Stewart, H. G., Bergemalm, D., Jonsson, P. A., Graffmo, K. S., Andersen, P. M., Brännström, T., Oliveberg, M., & Marklund, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700477104 · Cited by 170
Lead Exposure and Amyotrophic Lateral Sclerosis
Kamel, F., Umbach, D. M., Munsat, T. L., Shefner, J. M., Hu, H., & Sandler, D. P. (2002) · Epidemiology · doi:10.1097/00001648-200205000-00012 · Cited by 172
Misregulated RNA processing in amyotrophic lateral sclerosis
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Bennett, C. F., Cleveland, D. W., & Yeo, G. W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.059 · Cited by 169
“With the discovery of mutations in the gene encoding superoxide dismutase 1 (SOD1) as causative for 20% of inherited ALS (Rosen et al., 1993), and the generation of transgenic mice expressing ALS-causing SOD1 mutants (Bruijn et al., 1998; Gurney et al., 1994; Wong et al., 1995), the molecular era…”
BackgroundGlycation—a sweet tempter for neuronal death
Kikuchi, S. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00273-4 · Cited by 169
Molecular Neuropathology of TDP-43 Proteinopathies
Neumann, M. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10010232 · Cited by 169
“(SOD1) gene are thought to be the most common ones accounting for ~20% of fALS [29].”
BackgroundThe mitochondrial permeability transition in neurologic disease
NORENBERG, M., & RAO, K. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.02.008 · Cited by 169
“About 10% of ALS cases are familial and approximately 20% of these have mutations in superoxide dismutase 1 (SOD1) (Rosen et al., 1993).”
BackgroundKato, M., Yang, Y.-S., Sutter, B. M., Wang, Y., McKnight, S. L., & Tu, B. P. (2019) · Cell · doi:10.1016/j.cell.2019.02.044 · Cited by 169
The Regulation of Astrocytic Glutamate Transporters in Health and Neurodegenerative Diseases
Todd, A. C., & Hardingham, G. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249607 · Cited by 172
“Familial forms of ALS on the other hand were found to be associated with mutations in the superoxide dismutase gene (SOD1), with SOD1 mutant protein being shown to reduce functional EAAT2 protein levels in animal models by initiating the cleavage of EAAT2 by Caspase-3 [183–186].”
BackgroundTicozzi, N., Vance, C., LeClerc, A. L., Keagle, P., Glass, J. D., McKenna‐Yasek, D., Sapp, P. C., Silani, V., Bosco, D. A., Shaw, C. E., et al. (2011) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31158 · Cited by 169
Self-citationWang, Y., Ou Mao, X., Xie, L., Banwait, S., Marti, H. H., Greenberg, D. A., & Jin, K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4433-06.2007 · Cited by 168
“Patients with familial ALS have been found to have mutations in any of several genes, including Cu/Zn superoxide dismutase-1 (SOD1) (Rosen et al., 1993), alsin (Hadano et al., 2001; Yang et al., 2001), senataxin (Chen et al., 2004), vesicle-associated membrane protein B (Nishimura et al., 2004),…”
BackgroundInactivation of liver X receptor β leads to adult-onset motor neuron degeneration in male mice
Andersson, S., Gustafsson, N., Warner, M., & Gustafsson, J.-Å. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500634102 · Cited by 168
Nouri, Z., Fakhri, S., El-Senduny, F. F., Sanadgol, N., Abd-ElGhani, G. E., Farzaei, M. H., & Chen, J.-T. (2019) · Biomolecules · doi:10.3390/biom9110690 · Cited by 168
Hensley, K., Mhatre, M., Mou, S., Pye, Q. N., Stewart, C., West, M., & Williamson, K. S. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2075 · Cited by 168
Motor unit number estimation in human neurological diseases and animal models
Shefner, J. M. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00520-x · Cited by 167
Genetics of sporadic amyotrophic lateral sclerosis
Schymick, J. C., Talbot, K., & Traynor, B. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm215 · Cited by 169
The Physiological and Pathological Chemistry of Nitric Oxide
Beckman, J. S. (1996) · Nitric Oxide · doi:10.1016/b978-012435555-2/50002-4 · Cited by 166
Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo
Chi, L., Ke, Y., Luo, C., Gozal, D., & Liu, R. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.064 · Cited by 167
“Mutations of Cu,Zn-superoxide dismutase (SOD1) gene cause motor neuron degeneration and have linked to 2–5% of ALS cases (Rosen et al., 1994;Rosen et al., 1993).”
BackgroundMapping amyotrophic lateral sclerosis lake risk factors across northern New England
Torbick, N., Hession, S., Stommel, E., & Caller, T. (2014) · International Journal of Health Geographics · doi:10.1186/1476-072x-13-1 · Cited by 165
Bax and Bcl‐2 Interaction in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis
Vukosavic, S., Dubois‐Dauphin, M., Romero, N., & Przedborski, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732460.x · Cited by 167
Petri, S., Kiaei, M., Damiano, M., Hiller, A., Wille, E., Manfredi, G., Calingasan, N. Y., Szeto, H. H., & Beal, M. F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04018.x · Cited by 166
Kalmar, B., Novoselov, S., Gray, A., Cheetham, M. E., Margulis, B., & Greensmith, L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05595.x · Cited by 166
Extensive genetics of ALS: A population-based study in Italy
Chiò, A., Calvo, A., Mazzini, L., Cantello, R., Mora, G., Moglia, C., Corrado, L., D'Alfonso, S., Majounie, E., Renton, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182735d36 · Cited by 165
A Drosophila Model for Amyotrophic Lateral Sclerosis Reveals Motor Neuron Damage by Human SOD1
Watson, M. R., Lagow, R. D., Xu, K., Zhang, B., & Bonini, N. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804817200 · Cited by 163
ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2
Pedrini, S., Sau, D., Guareschi, S., Bogush, M., Brown, R. H., Naniche, N., Kia, A., Trotti, D., & Pasinelli, P. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq202 · Cited by 165
“Three percent of ALS arises from mutations in copper–zinc superoxide dismutase [SOD1 (2)] which acquires new toxic functions not fully defined (1).”
BackgroundSelf-citationThe role of flavonoids in autoimmune diseases: Therapeutic updates
Rengasamy, K. R. R., Khan, H., Gowrishankar, S., Lagoa, R. J. L., Mahomoodally, F. M., Khan, Z., Suroowan, S., Tewari, D., Zengin, G., Hassan, S. T. S., et al. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.009 · Cited by 166
“enzyme in first line of defence against superoxide-triggered oxidative stress (Rosen et al., 1993).”
BackgroundBeers, D. R., Ho, B., Siklós, L., Alexianu, M. E., Mosier, D. R., Mohamed, A. H., Otsuka, Y., Kozovska, M. E., McAlhany, R. E., Smith, R. G., et al. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00582.x · Cited by 166
Vukosavic, S., Stefanis, L., Jackson-Lewis, V., Guégan, C., Romero, N., Chen, C., Dubois-Dauphin, M., & Przedborski, S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09119.2000 · Cited by 166
Copper-binding motifs in catalysis, transport, detoxification and signaling
Koch, K. A., Peña, M. M. O., & Thiele, D. J. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90241-6 · Cited by 166
An Unusual Member of the Cdk Family: Cdk5
Dhariwala, F. A., & Rajadhyaksha, M. S. (2008) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9242-1 · Cited by 164
Goto, J. J., Zhu, H., Sanchez, R. J., Nersissian, A., Gralla, E. B., Valentine, J. S., & Cabelli, D. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1007 · Cited by 166
Self-citationApoptosis in amyotrophic lateral sclerosis: a review of the evidence
Sathasivam, S., Ince, P. G., & Shaw, P. J. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00332.x · Cited by 166
MATTSON, M. P. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44401.x · Cited by 166
Dissection of genetic factors associated with amyotrophic lateral sclerosis
Leblond, C. S., Kaneb, H. M., Dion, P. A., & Rouleau, G. A. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.013 · Cited by 165
“The mutated gene in this locus was subsequently identified by single-strand conformational polymorphism analysis to be SOD1 and direct sequencing of SOD1 exons allowed the identification of several missense mutations (Rosen et al., 1993).”
BackgroundSelf-citationSigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice
Mancuso, R., Oliván, S., Rando, A., Casas, C., Osta, R., & Navarro, X. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0140-y · Cited by 165
“Among these cases, mutations in the gene encoded for the enzyme Cu/Zn superoxide dismutase 1 (SOD1) are observed in approximately 20 % [2].”
BackgroundRocha, M. C., Pousinha, P. A., Correia, A. M., Sebastião, A. M., & Ribeiro, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073846 · Cited by 165
“The ear tissue extracted during the tagging procedure was then used to run a polymerase chain reaction (PCR) and genotype the progeny [11].”
MethodVitamin E intake and risk of amyotrophic lateral sclerosis
Ascherio, A., Weisskopf, M. G., O'Reilly, E. J., Jacobs, E. J., McCullough, M. L., Calle, E. E., Cudkowicz, M., & Thun, M. J. (2005) · Annals of Neurology · doi:10.1002/ana.20316 · Cited by 165
“Oxidative stress appears to act in concert with other mechanisms that have been implicated in the pathogenesis of motor neuron degeneration in ALS.33 Thus, oxidative reactions increase the susceptibility of motor neurons to excitotoxicity by disrupting glial glutamate transport,34–37 modulate immune activation,33 affe…”
BackgroundInfluentialLiu, R., Althaus, J. S., Ellerbrock, B. R., Becker, D. A., & Gurney, M. E. (1998) · Annals of Neurology · doi:10.1002/ana.410440510 · Cited by 164
The microglial component of amyotrophic lateral sclerosis
Clarke, B. E., & Patani, R. (2020) · Brain · doi:10.1093/brain/awaa309 · Cited by 164
Bilsland, L. G., Dick, J. R. T., Pryce, G., Petrosino, S., Di Marzo, V., Baker, D., Greensmith, L., Bilsland, L. G., Dick, J. R. T., Pryce, G., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4743fje · Cited by 164
Ramesh, T., Lyon, A. N., Pineda, R. H., Wang, C., Janssen, P. M. L., Canan, B. D., Burghes, A. H. M., & Beattie, C. E. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005538 · Cited by 163
“Mutations in the superoxide dismutase (SOD1) gene account for 20% of FALS cases (Deng et al., 1993; Rosen et al., 1993; Valdmanis and Rouleau, 2008).”
BackgroundCampos-Melo, D., Droppelmann, C. A., He, Z., Volkening, K., & Strong, M. J. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-26 · Cited by 164
“The pathology and alterations in expression of RNA binding proteins such as mutant SOD1 (mtSOD1), TDP-43 and FUS/TLS in ALS, as well as evidence of mutations in these proteins being associated with altered RNA processing, has suggested that alterations in the metabolism of RNA may be critical to the pathogenesis of AL…”
BackgroundWild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS
Estes, P. S., Boehringer, A., Zwick, R., Tang, J. E., Grigsby, B., & Zarnescu, D. C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr124 · Cited by 164
The Emergence of Modern Neuroscience: Some Implications for Neurology and Psychiatry
Cowan, W. M., Harter, D. H., & Kandel, E. R. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.343 · Cited by 164
Amyotrophic Lateral Sclerosis: Insights From Genetics
Brown, R. H. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550220050013 · Cited by 164
Self-citationTransgenic mouse models of amyotrophic lateral sclerosis
Julien, J.-P., & Kriz, J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.006 · Cited by 163
Lewitt, M. S., & Boyd, G. W. (2019) · Biochemistry Insights · doi:10.1177/1178626419842176 · Cited by 161
Harper, P. S., Lim, C., & Craufurd, D. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.8.567 · Cited by 163
“17 These are mostly very rare and practical experience of presymptomatic testing for them remains limited.”
BackgroundRobberecht, W., Sapp, P., Viaene, M. K., Rosen, D., McKenna‐Yasek, D., Haines, J., Horvitz, R., Theys, P., & Brown, R. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62010384.x · Cited by 163
Self-citationSOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis
Tafuri, F., Ronchi, D., Magri, F., Comi, G. P., & Corti, S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00336 · Cited by 162
“SOD1 mutations have been the first molecular defects described in fALS forms with dominant inheritance (Rosen et al., 1993) and most of the research studies addressing ALS pathogenesis and the development of therapeutic strategies have been performed using SOD1 transgenic models (Gurney et al.,…”
MethodGandelman, M., Peluffo, H., Beckman, J. S., Cassina, P., & Barbeito, L. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-33 · Cited by 162
Iuchi, Y., Okada, F., Onuma, K., Onoda, T., Asao, H., Kobayashi, M., & Fujii, J. (2007) · Biochemical Journal · doi:10.1042/bj20061386 · Cited by 162
“The finding that a mutation in SOD1 is a cause of familial ALS (amyotrophic lateral sclerosis) has attracted the interest of many neurologists and other researchers [7, 8 ].”
BackgroundMitochondrial DNA mutations in neurodegeneration
Keogh, M. J., & Chinnery, P. F. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.05.015 · Cited by 161
Martin, L. J., Chen, K., & Liu, Z. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0911-05.2005 · Cited by 161
“MNs in individuals with ALS sustain DNA damage (Ferrante et al., 1997; McClendon and Martin, 2003), and the tumor suppressor protein p53 may participate in the mechanisms of MN apoptosis in ALS (Martin, 2000).”
BackgroundInfluentialImpaired antioxidant defense at the onset of psychosis
Mukherjee, S., Mahadik, S. P., Scheffer, R., Correnti, E. E., & Kelkar, H. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00048-8 · Cited by 161
Matsumoto, G., Stojanovic, A., Holmberg, C. I., Kim, S., & Morimoto, R. I. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504050 · Cited by 162
“Although a number of genetic defects have been linked to the development of fALS, the autosomal-dominant inheritance of mutant Cu/Zn superoxide dismutase 1 (SOD1) accounts for 20% of cases (Rosen et al., 1993).”
Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan, N. Y., Crow, J. P., & Beal, M. F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.013 · Cited by 161
Lee, D.-H., Gold, R., & Linker, R. A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911783 · Cited by 160
“In contrast, SOD1 expression in neuronal cells is rather associated with the onset of symptoms [45–47].”
BackgroundInfluentialNeural cell cycle dysregulation and central nervous system diseases
Wang, W., Bu, B., Xie, M., Zhang, M., Yu, Z., & Tao, D. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.007 · Cited by 159
Epigenetic Regulatory Mechanisms Induced by Resveratrol
Fernandes, G., Silva, G., Pavan, A., Chiba, D., Chin, C., & Dos Santos, J. (2017) · Nutrients · doi:10.3390/nu9111201 · Cited by 161
“An interesting finding in ALS was the identification of mutations in the gene encoding SOD1 (superoxide dismutase 1), which were observed in 20% of inherited ALS cases [194].”
BackgroundGenome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
Ben Jehuda, R., Shemer, Y., & Binah, O. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9811-3 · Cited by 161
Babiychuk, E., Kushnir, S., Belles-Boix, E., Van Montagu, M., & Inzé, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26224 · Cited by 161
Khare, S. D., Caplow, M., & Dokholyan, N. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406650101 · Cited by 161
Al-Chalabi, A. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.13.2045 · Cited by 159
Nguyen, M. D., Boudreau, M., Kriz, J., Couillard-Després, S., Kaplan, D. R., & Julien, J.-P. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02131.2003 · Cited by 161
“Missense mutations in the gene coding for Cu/Zn superoxide dismutase 1 (SOD1), located on chromosome 21, account for ϳ3% of all ALS cases (Rosen et al., 1993; Cudkowicz et al., 1997).”
BackgroundDodge, J. C., Haidet, A. M., Yang, W., Passini, M. A., Hester, M., Clarke, J., Roskelley, E. M., Treleaven, C. M., Rizo, L., Martin, H., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.60 · Cited by 160
ER Stress and Unfolded Protein Response in Amyotrophic Lateral Sclerosis
Kanekura, K., Suzuki, H., Aiso, S., & Matsuoka, M. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8054-3 · Cited by 160
“In 1993, an international research team identified the first familial ALS-linked gene, Cu/Zn superoxide dismutase (SOD1), from autosomal-dominant ALS patients [12].”
BackgroundAnalysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort
Ticozzi, N., Silani, V., LeClerc, A. L., Keagle, P., Gellera, C., Ratti, A., Taroni, F., Kwiatkowski, T. J., McKenna-Yasek, D. M., Sapp, P. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bbff05 · Cited by 160
Self-citationZhang, S., Binari, R., Zhou, R., & Perrimon, N. (2010) · Genetics · doi:10.1534/genetics.109.112516 · Cited by 160
SOD1 in Amyotrophic Lateral Sclerosis: “Ambivalent” Behavior Connected to the Disease
Pansarasa, O., Bordoni, M., Diamanti, L., Sproviero, D., Gagliardi, S., & Cereda, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051345 · Cited by 160
“Starting from SOD1, whose discovery in 1993 made it the first ALS gene to be identified [3], at least 25 genes have been implicated in familial ALS (fALS), sporadic ALS (sALS), or both.”
BackgroundDistinct cerebral lesions in sporadic and ‘D90A’ SOD1 ALS: studies with [11C]flumazenil PET
Turner, M. R., Hammers, A., Al-Chalabi, A., Shaw, C. E., Andersen, P. M., Brooks, D. J., & Leigh, P. N. (2005) · Brain · doi:10.1093/brain/awh509 · Cited by 160
“SE5 8AF, UK E-mail: n.leigh@iop.kcl.ac.uk”
BackgroundMethodInfluentialCorson, L. B., Strain, J. J., Culotta, V. C., & Cleveland, D. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6361 · Cited by 160
Alterations in G1 to S Phase Cell-Cycle Regulators during Amyotrophic Lateral Sclerosis
Ranganathan, S., & Bowser, R. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63879-5 · Cited by 160
Uccelli, A., Milanese, M., Principato, M. C., Morando, S., Bonifacino, T., Vergani, L., Giunti, D., Voci, A., Carminati, E., Giribaldi, F., et al. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00498 · Cited by 160
“Most ALS cases are sporadic, while approximately 10% are inherited, sometimes because of mutations in the Cu/Zn superoxide dismutase (SOD1) gene (3) that induce MN killing by an unknown gain of toxicity.”
BackgroundJohnson, F. O., & Atchison, W. D. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.07.010 · Cited by 159
“However, in the mouse model of ALS, overexpressing the mutant human SOD1 gene (TgN SOD1G93A), chronic exposure to methylmercury induced early onset of hind limb weakness characteristic of this model (Johnson and Atchison, 2008).”
InfluentialShan, Y., Schoenfeld, R. A., Hayashi, G., Napoli, E., Akiyama, T., Iodi Carstens, M., Carstens, E. E., Pook, M. A., & Cortopassi, G. A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4537 · Cited by 159
“Oxidative stress is suspected to be important in neurodegenerative diseases, including Lou Gehrig’s disease (ALS), Parkinson’s disease, Alzheimer’s disease, and Huntington’s disease (54).”
BackgroundCheroni, C., Marino, M., Tortarolo, M., Veglianese, P., De Biasi, S., Fontana, E., Zuccarello, L. V., Maynard, C. J., Dantuma, N. P., & Bendotti, C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn319 · Cited by 159
“In 5– 10% of patients the disease is inherited and 20% of these are associated with mutations in the gene coding for Cu,Zn superoxide dismutase (SOD1) (3).”
BackgroundLiu, M.-L., Zang, T., & Zhang, C.-L. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.018 · Cited by 158
Balderston, S., Taulbee, J. J., Celaya, E., Fung, K., Jiao, A., Smith, K., Hajian, R., Gasiunas, G., Kutanovas, S., Kim, D., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00706-z · Cited by 158
Genetics and molecular biology of Huntington's disease
Albin, R. L., & Tagle, D. A. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93943-r · Cited by 160
Metadata
- Authors
- Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., Van den Bergh, R., Hung, W.-Y., Bird, T., Deng, G., Mulder, D. W., Smyth, C., Laing, N. G., Soriano, E., Pericak–Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., & Brown, R. H.
- Affiliations
- Massachusetts General Hospital (US)
- Northwestern University (US)
- Montreal General Hospital (CA)
- Howard Hughes Medical Institute (US)
- North Shore University Hospital (US)
- University of Washington (US)
- Mayo Clinic (US)
- ORCID
- Venue
- Nature
- Published
- 1993-03-01
- Volume
- 362
- Issue
- 6415
- Pages
- 59-62
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2096386031
- Cited by
- 7,062
- References
- 42
- Citations by year
- 2026: 137 · 2025: 154 · 2024: 201 · 2023: 185 · 2022: 254 · 2021: 259 · 2020: 295 · 2019: 205 · 2018: 258 · 2017: 248 · 2016: 242 · 2015: 248 · 2014: 262 · 2013: 264 · 2012: 315
- FWCI
- 174.77
- Type
- journal article
- Language
- en
- Update notices
- correction (1993-07-22)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, familial ALS, SOD1, Cu/Zn superoxide dismutase, missense mutations, genetic linkage, chromosome 21q, autosomal dominant inheritance, free radical toxicity, candidate genes, motor neuron degeneration
- MeSH terms
- Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Base Sequence, Codon, DNA, Exons, Humans, Isoenzymes, Lod Score, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Oligodeoxyribonucleotides, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, Superoxide Dismutase, Genome, Human, Polymerase Chain Reaction, Sequence Homology, Amino Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.